Concepedia

Shuwei Liang

SL

Statistics

Publications

5

Citations

446

H-Index

5

Active since

2016

Affiliations

Australian Regenerative Medicine Institute(Current)

The University of Melbourne

Monash University

State Key Laboratory of Oncology in South China

Hunan Cancer Hospital

Shuwei Liang is an author at Australian Regenerative Medicine Institute specializing in molecular oncology, oncology, and medicine.

Publications per year

2016–2023

5

Publications

5

PTPN2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumours

Florian Wiede, Kun‐Hui Lu, Xin Du et al. · The EMBO Journal · 2019 · 139 citations · Full text

Life Sciences, Immunology, Oncology +14

Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals

Shuwei Liang, Zhuojia Chen, Guanmin Jiang et al. · Cancer Letters · 2016 · 138 citations

Medicine, Cancer Biology, Oncology +14

A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity

Shuwei Liang, Eric Tran, Xin Du et al. · Nature Communications · 2023 · 83 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

PTPN2 elicits cell autonomous and non–cell autonomous effects on antitumor immunity in triple-negative breast cancer

Pei Kee Goh, Florian Wiede, Mara N. Zeissig et al. · Science Advances · 2022 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways

Yingmin Wu, Zhuojia Chen, Guanmin Jiang et al. · Oncotarget · 2016 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 5